Cana­di­an CRO Al­ta­sciences kicks off client man­u­fac­tur­ing ex­pan­sion in Philadel­phia

As Philadel­phia con­tin­ues to gar­ner the in­ter­est of com­pa­nies like WuXi AppTec and SK, a Que­bec-based CRO is al­so look­ing to ex­pand man­u­fac­tur­ing op­er­a­tions in the City of Broth­er­ly Love on be­half of a client.

Al­ta­sciences, a drug for­mu­la­tion and man­u­fac­tur­ing CRO, is con­struct­ing a man­u­fac­tur­ing fa­cil­i­ty for Cal­i­for­nia-based Al­ladapt Im­munother­a­peu­tics in the greater Philadel­phia area. Al­ladapt is cur­rent­ly de­vel­op­ing a pre­ci­sion ther­a­peu­tic to ad­dress IgE-me­di­at­ed food al­ler­gies.

To read Endpoints News become a free subscriber

Unlock this article instantly, along with access to limited free monthly articles and our suite of newsletters

SIGN UP LOG IN